[Manic-depressive psychoses. Chronic treatment with tricyclic antidepressive agents].
Long-course Tricyclic anti-depressing treatment affonds clinical healing--i.e. abolition of the recurrences--in melancolic unipolary periodic depressions. This treatment--T.A.T.C.--allows a good prevention of melancolic recurrences in bipolar periodic patterns of psychosis. For the authors Lithium and/or Dipropylacétamide are not sufficient protection for melancolic or maniac recurrences in this patterns. It seems to be three patterns in fact: pure melancolic, pure maniac, and maniaco-depressive. Therapeutic and psychopathologic considerations.
D000328:Adult; D000368:Aged; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014635:Valproic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D014635:Valproic Acid; D008094:Lithium
Psychose maniaco-dépressive. Traitement antidépresseur tricyclique chronique.